Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessStocksAvoid Ranbaxy Laboratories: Sandip Sabharwal

SHOW NAMES

Trending Topics

business

Avoid Ranbaxy Laboratories: Sandip Sabharwal

Sandip Sabharwal of Prabhudas Lilladher advises to avoid Ranbaxy Laboratories and focus on the companies which are actually doing well.

first published: Jun 26, 2013 06:24 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Will The Pre-Diwali Nifty Rally Rage On Amid Weak Global Cues? RIL Q2 in Focus | Opening Bell Live
Infosys Q2 Earnings Live | Decoding Infosys Q2 Earnings | Earnings Express
Indian stocks Vs Gold, Silver, Global equities: Manish Chokhani on where to sow, where to harvest
Can Nifty Reclaim 25,400 After Strong Comeback; Infosys, Axis, Eternal In Focus|Opening Bell Live

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347